Advertisement.

COYA Projected Dividend Yield

Coya Therapeutics Inc ( NASDAQ : COYA )

Coya Therapeutics is a clinical-stage biotechnology company focused on developing therapies to improve the function of regulatory T cells ("Tregs"). Tregs consist of CD4+CD25high hFOXP3+ cells, which are a subpopulation of T-lymphocytes. Co. has product candidate pipeline that includes both ex vivo and in vivo therapeutic approaches intended to restore the suppressive and immunomodulatory functions of Tregs. Co.'s product candidate pipeline is based on: Treg-enhancing biologics; Treg-derived exosomes (a sac-like structures that are formed inside a cell and contain some of the cell's proteins, lipids, and nucleic acids); and autologous (obtained from the same individual) Treg cell therapy.

20 YEAR PERFORMANCE RESULTS

COYA Dividend History Detail
COYA Dividend News
COYA Competitors News

# of Shares: 0

Closing Price: 8.40

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000